Insecticides (India) Limited (INSECTICID.NS)
Delhi, IN
Insecticides (India) Limited operates as a prominent entity within the agrochemical industry, engaging in the manufacture and global sale of a diverse array of agricultural products, primarily for crop protection and enhancement. The company's extensive product line includes insecticides, herbicides, fungicides, and plant growth regulators (PGRs), alongside bio-fertilizers. Furthermore, they supply household pest control solutions, biological products, and various chemical formulations. Its offerings reach consumers through a robust sales network comprising roughly 5,000 distributors and 60,000 retailers, all operating under the widely recognized 'Tractor' brand. Established in 1996, the firm maintains its headquarters in Delhi, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.93% | -3.30% | +4.78% | +18.34% | +1.52% | +2.55% | -12.39% | +65.34% | +111.82% | +161.82% | +1,409.55% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-01 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%+7.0% Q1'26: +18.8% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%-3.5% Q1'26: +3.6% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+2.7% ★ Q1'26: -38.0% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+9.0% Q1'26: +3.8% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+11.2% ★ Q1'26: +3.7% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%+1.7% Q1'26: -19.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×0.67× Q1'26: 1.48× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2012 actual |
Mar 2013 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.22B
est: 5.62B (-7.2%)
|
6.17B
est: 5.99B (+2.9%)
|
8.92B
est: 10.06B (-11.3%)
|
9.06B
est: 9.71B (-6.7%)
|
9.94B
est: 11.22B (-11.4%)
|
10.72B
est: 11.34B (-5.5%)
|
11.89B
est: 11.81B (+0.7%)
|
13.50B
est: 13.28B (+1.6%)
|
14.12B
est: 14.19B (-0.5%)
|
14.98B
est: 15.05B (-0.4%)
|
17.97B
est: 17.84B (+0.7%)
|
19.56B
est: 20.36B (-3.9%)
|
20.00B
est: 21.63B (-7.5%)
|
21.20B
21.20B – 21.20B
-2.0% YoY
|
24.38B
24.38B – 24.38B
+15.0% YoY
|
26.82B
26.82B – 26.82B
+10.0% YoY
|
| EBITDA |
453.05M
est: 550.96M (-17.8%)
|
693.17M
est: 380.15M (+82.3%)
|
1.11B
est: 986.04M (+13.1%)
|
927.40M
est: 651.73M (+42.3%)
|
1.14B
est: 1.10B (+4.0%)
|
1.50B
est: 892.11M (+67.9%)
|
1.85B
est: 1.26B (+47.5%)
|
1.56B
est: 1.76B (-11.5%)
|
1.48B
est: 1.21B (+22.5%)
|
1.73B
est: 1.36B (+27.2%)
|
1.21B
est: 1.56B (-22.4%)
|
1.72B
est: 1.74B (-1.0%)
|
2.29B
est: 2.59B (-11.8%)
|
2.54B
2.54B – 2.54B
-2.0% YoY
|
2.92B
2.92B – 2.92B
+15.0% YoY
|
3.21B
3.21B – 3.21B
+10.0% YoY
|
| EBIT |
429.48M
est: 461.99M (-7.0%)
|
635.52M
est: 576.73M (+10.2%)
|
973.25M
est: 826.82M (+17.7%)
|
762.82M
est: 988.74M (-22.8%)
|
983.32M
est: 922.07M (+6.6%)
|
1.33B
est: 1.01B (+32.1%)
|
1.66B
est: 1.36B (+21.8%)
|
1.32B
est: 1.93B (-31.8%)
|
1.23B
est: 1.47B (-16.3%)
|
1.46B
est: 1.66B (-11.6%)
|
951.12M
est: 1.91B (-50.1%)
|
1.43B
est: 2.12B (-32.6%)
|
2.00B
est: 2.26B (-11.5%)
|
2.21B
2.21B – 2.21B
-2.0% YoY
|
2.54B
2.54B – 2.54B
+15.0% YoY
|
2.80B
2.80B – 2.80B
+10.0% YoY
|
| Net Income |
330.15M
est: 616.81M (-46.5%)
|
353.18M
est: 351.79M (+0.4%)
|
548.39M
est: 729.31M (-24.8%)
|
395.83M
est: 603.11M (-34.4%)
|
596.99M
est: 575.36M (+3.8%)
|
842.91M
est: 612.73M (+37.6%)
|
1.23B
est: 865.85M (+41.8%)
|
869.13M
est: 1.38B (-37.2%)
|
939.03M
est: 934.73M (+0.5%)
|
1.07B
est: 1.05B (+2.3%)
|
632.11M
est: 1.21B (-47.7%)
|
1.02B
est: 1.34B (-23.8%)
|
1.42B
est: 1.39B (+2.5%)
|
1.56B
1.56B – 1.56B
+12.3% YoY
|
1.91B
1.91B – 1.91B
+23.0% YoY
|
2.03B
2.03B – 2.03B
+6.1% YoY
|
| SGA |
900.72M
est: 166.93M (+439.6%)
|
958.66M
est: 1.05B (-8.7%)
|
1.41B
est: 298.74M (+370.9%)
|
283.97M
est: 1.80B (-84.2%)
|
97.50M
est: 333.16M (-70.7%)
|
200.84M
est: 1.14B (-82.3%)
|
131.66M
est: 1.34B (-90.1%)
|
119.89M
est: 1.58B (-92.4%)
|
171.84M
est: 1.54B (-88.9%)
|
179.06M
est: 1.73B (-89.7%)
|
417.38M
est: 1.99B (-79.0%)
|
1.27B
est: 2.22B (-42.6%)
|
722.16M
est: 1.16B (-38.0%)
|
1.14B
1.14B – 1.14B
-2.0% YoY
|
1.31B
1.31B – 1.31B
+15.0% YoY
|
1.44B
1.44B – 1.44B
+10.0% YoY
|
| EPS |
11.57
est: 21.01 (-44.9%)
|
12.38
est: 19.96 (-38.0%)
|
28.83
est: 24.84 (+16.0%)
|
12.77
est: 14.45 (-11.6%)
|
19.25
est: 19.60 (-1.8%)
|
27.19
est: 29.04 (-6.4%)
|
39.61
est: 35.07 (+12.9%)
|
28.03
est: 39.18 (-28.5%)
|
30.29
est: 29.64 (+2.2%)
|
36.17
est: 38.80 (-6.8%)
|
21.36
est: 42.38 (-49.6%)
|
34.59
est: 34.45 (+0.4%)
|
48.38
est: 46.40 (+4.3%)
|
52.10
52.10 – 52.10
+12.3% YoY
|
64.10
64.10 – 64.10
+23.0% YoY
|
68.00
68.00 – 68.00
+6.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hari Chand Aggarwal | Executive Chairman | 53M | male |
| Rajesh Kumar Aggarwal | Chief Executive Officer, MD & Executive Director | 52M | male |
| Anil Kumar Goyal | Whole-Time Director | 2M | male |
| Nikunj Aggarwal | Whole-Time Director | 2M | female |
| Srikant S. Satwe | Head of International Business | — | male |
| Devendra Kumar Ray | Chief Operating Officer | — | male |
| S. A. Khan | Senior Manager of Human Resources | — | male |
| Sandeep Kumar | Chief Compliance Officer & Company Secretary | — | male |
| Sanskar Aggarwal | Executive VP & Whole Time Director | — | male |
| Dushyant Sood | Chief Marketing Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for INSECTICID.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
